Genflow Biosciences (GENF)

Sector:

Pharma and Biotech

 1.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.30
  • 52 Week Low: 1.38
  • Currency: UK Pounds
  • Shares Issued: 349.71m
  • Volume: 550,706
  • Market Cap: £6.12m
  • Beta: 0.56

GENF Overview

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 8.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GENF Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (0.99) (0.59)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.34) (0.46)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (1.63) (0.56)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GENF Company Announcements

Genflow Secures Non-Dilutive Financial Support 22-Oct-2024 07:00 RNS
Half-year Report 30-Sep-2024 07:00 RNS
Result of AGM 27-Jun-2024 13:30 RNS

GENF ShareCast News

No recent information was found.

Latest GENF Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

GENF Market Data

Currency UK Pounds
Share Price 1.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.30
52 Week Low 1.38
Volume 550,706
Shares Issued 349.71m
Market Cap £6.12m
Beta 0.56

GENF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.45% below the market average57.45% below the market average57.45% below the market average57.45% below the market average57.45% below the market average
64% below the sector average64% below the sector average64% below the sector average64% below the sector average64% below the sector average
Price Trend
38.07% below the market average38.07% below the market average38.07% below the market average38.07% below the market average38.07% below the market average
26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average
Income Not Available
Growth Not Available

GENF Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:27 15,000 @ 1.79p
15:49 500 @ 1.79p
15:19 502 @ 1.76p
14:39 167 @ 1.79p
11:36 62,500 @ 1.76p

GENF Key Personnel

CEO Eric Leire

Top of Page